Artículo de revista
Factors associated with success of a smoking cessation program Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario
Fecha
2016Registro en:
Revista Medica de Chile, Volumen 144, Issue 8, 2018, Pages 965-971
07176163
00349887
Autor
Peña, Pedro
Zagolin, Mónica
Acuña, Mónica
Navarrete, Sandra
Bustamante, Pilar
Canals Cifuentes, Andrea
Institución
Resumen
© 2016, Sociedad Medica de Santiago. All right reserved. Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available. Aim: To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients and Methods: Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program. Results: The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction l